Long-Term Effects of Treatment in Patients Previously Treated for Childhood Hodgkin's Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Debra L. Friedman, MD, MS
Vanderbilt-Ingram Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Lucile Packard Children'S Hospital at Stanford University Medical Center
Palo Alto, California, United States
- Yale Cancer Center
New Haven, Connecticut, United States
- University of Chicago Cancer Research Center
Chicago, Illinois, United States
- Hackensack University Medical Center Cancer Center
Hackensack, New Jersey, United States
- Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center
New York, New York, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- James P. Wilmot Cancer Center at University of Rochester Medical Center
Rochester, New York, United States
- Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
- Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
- Rhode Island Hospital Comprehensive Cancer Center
Providence, Rhode Island, United States
- St. Jude Children'S Research Hospital
Memphis, Tennessee, United States
- Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, United States
- Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
Dallas, Texas, United States
- Children'S Hospital and Regional Medical Center - Seattle
Seattle, Washington, United States
- St. Vincent Hospital Regional Cancer Center
Green Bay, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2004
- Primary completion
- 27 Jun 2011
- Completion
- —
- Last update posted
- 16 Jul 2018
- Registered enrollment
- 530
- Registry id
- NCT00091091
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.